Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone844-428-2667
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$652.30 million
Profitability
Miscellaneous
Employees4,700
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable
Avanos Medical (NYSE:AVNS) Frequently Asked Questions
What is Avanos Medical's stock symbol?
Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."
How were Avanos Medical's earnings last quarter?
Avanos Medical Inc (NYSE:AVNS) issued its quarterly earnings data on Tuesday, August, 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.03. The firm earned $172.20 million during the quarter, compared to the consensus estimate of $172.02 million. Avanos Medical had a negative net margin of 3.92% and a positive return on equity of 4.18%. The company's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.20 EPS. View Avanos Medical's Earnings History.
When is Avanos Medical's next earnings date?
What guidance has Avanos Medical issued on next quarter's earnings?
Avanos Medical issued an update on its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of $1.15-1.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.23.
What price target have analysts set for AVNS?
6 brokers have issued twelve-month price targets for Avanos Medical's shares. Their predictions range from $45.00 to $65.00. On average, they anticipate Avanos Medical's stock price to reach $51.25 in the next year. This suggests a possible upside of 21.4% from the stock's current price. View Analyst Price Targets for Avanos Medical.
What is the consensus analysts' recommendation for Avanos Medical?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.
Has Avanos Medical been receiving favorable news coverage?
News headlines about AVNS stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avanos Medical earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Avanos Medical.
Who are some of Avanos Medical's key competitors?
Some companies that are related to Avanos Medical include DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), RTI Surgical (RTIX), ConforMIS (CFMS), Lakeland Industries (LAKE), Histogenics (HSGX), Rewalk Robotics (RWLK), COLLPLANT HOLDI/S (CLGN), Precision Therapeutics (POAI) and NanoVibronix (NAOV).
What other stocks do shareholders of Avanos Medical own?
Who are Avanos Medical's key executives?
Avanos Medical's management team includes the folowing people:
- Mr. Joseph F. Woody, CEO & Director (Age 53)
- Mr. John W. Wesley, Sr. VP of Legal & Gov. Relations (Age 60)
- Mr. John R. Tushar, Pres of Global Franchises (Age 57)
- Mr. Arjun Ranjan Sarker, Sr. VP of International (Age 53)
- Mr. Warren J. MacHan, Sr. VP of Bus. Strategy & Interim CFO (Age 53)
Who are Avanos Medical's major shareholders?
Avanos Medical's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Alberta Investment Management Corp (0.51%), Rhumbline Advisers (0.34%), Confluence Investment Management LLC (0.29%), State of New Jersey Common Pension Fund D (0.11%), Pacer Advisors Inc. (0.04%) and Virginia Retirement Systems ET AL (0.02%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.
Which institutional investors are selling Avanos Medical stock?
Which institutional investors are buying Avanos Medical stock?
AVNS stock was purchased by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Confluence Investment Management LLC, Alberta Investment Management Corp, Virginia Retirement Systems ET AL, State of Alaska Department of Revenue, Rhumbline Advisers, North Star Investment Management Corp. and Nisa Investment Advisors LLC. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.
How do I buy shares of Avanos Medical?
Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Avanos Medical's stock price today?
One share of AVNS stock can currently be purchased for approximately $42.21.
How big of a company is Avanos Medical?
Avanos Medical has a market capitalization of $2.01 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.
What is Avanos Medical's official website?
How can I contact Avanos Medical?
Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]
MarketBeat Community Rating for Avanos Medical (NYSE AVNS)
MarketBeat's community ratings are surveys of what our community members think about Avanos Medical and other stocks. Vote "Outperform" if you believe AVNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
